Resilience Phenotypes and Psychological Functioning among Individuals with Opioid Use Disorder

被引:0
|
作者
Martinez, Suky [1 ,2 ]
Garcia-Romeu, Albert [3 ]
Perez, Freymon [1 ,2 ]
Jones, Jermaine D. [1 ,2 ]
机构
[1] Columbia Univ, Vagelos Coll Phys & Surg, Dept Psychiat, Div Subst Use Disorders, New York, NY 10027 USA
[2] New York State Psychiat Inst & Hosp, New York, NY 10032 USA
[3] Johns Hopkins Univ, Dept Psychiat & Behav Sci, Behav Pharmacol Res Unit, Sch Med, Baltimore, MD USA
关键词
Resilience; opioid use disorder; heroin; five factor model of personality; heterogeneity; NEO-PI-R; DEPRESSION-INVENTORY-II; SUBSTANCE USE DISORDERS; PERSONALITY-TRAITS; TELOMERE LENGTH; MODERATING ROLE; DRUG-USE; ADDICTION; HEALTH; CONSCIENTIOUSNESS;
D O I
10.1080/10826084.2023.2259450
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
Background: Opioid use disorder (OUD) is a heterogeneous disorder. However, there is a lack of deep phenotyping investigations focusing on important psychological constructs such as resilience that may impact OUD. The present study aimed to investigate the relationship between trait resilience and the five-factor model of personality (FFM) among individuals with opioid use disorder (OUD). We also explored whether the FFM and trait resilience form specific phenotypes associated with psychological functioning. Methods: This secondary analysis of an epigenetic study included participants of African ancestry (n = 72), an understudied population, who met DSM-5 criteria for OUD. Participants completed measures to assess personality traits, trait resilience, current and previous drug use, and psychological functioning (depression, anxiety, and stress). Results: Linear regression revealed a significant relationship between resilience (CD-RISC-25 score) and the FFM, R-2 = 0.56, F(5,62) = 15.7, p<.001. Further, a two-cluster classification emerged as the optimal solution from the cluster analysis. Cluster 1 (n = 33, 45.8% of the sample) showed lower resilience (CD-RISC-25 score: M = 58.6, SD = 11.2) compared to Cluster 2 (n = 35, 48.6%; CD-RISC-25 score: M = 76.1, SD = 11.9). The "High-Resilience Cluster" (Cluster 2) was characterized by higher FFM traits of: Extraversion, Openness, Agreeableness, and Conscientiousness, and lower Neuroticism versus Cluster 1. Multivariate analysis of variance revealed statistically significant differences between the two resilience clusters concerning other psychological symptoms, ? = 0.732, F(4, 50) = 7.05, p < 0.003. Conclusions: These findings suggest associations between the FFM and trait resilience among individuals with OUD. Two distinct "resilience phenotypes" emerged, with high-resilience individuals displaying less stress, anxiety, and depressive symptoms. Results highlight the clinical importance of resilience as a potential target for intervention in people with OUD.
引用
收藏
页码:41 / 49
页数:9
相关论文
共 50 条
  • [21] Perspectives Regarding Medications for Opioid Use Disorder Among Individuals with Mental Illness
    Tarn, Derjung M.
    Shih, Kevin J.
    Ober, Allison J.
    Hunter, Sarah B.
    Watkins, Katherine E.
    Martinez, Jeremy
    Montero, Alanna
    McCreary, Michael
    Leamon, Isabel
    Sheehe, John
    Bromley, Elizabeth
    COMMUNITY MENTAL HEALTH JOURNAL, 2023, 59 (02) : 345 - 356
  • [22] Polydrug use disorders in individuals with opioid use disorder
    Hassan, Ahmed N.
    Le Foll, Bernard
    DRUG AND ALCOHOL DEPENDENCE, 2019, 198 : 28 - 33
  • [23] Association Between Length of Buprenorphine or Methadone Use and Nonprescribed Opioid Use Among Individuals with Opioid Use Disorder: A Cohort Study
    Jiang, Xinyi
    Guy Jr, Gery P.
    Dever, Jill A.
    Richardson, John S.
    Dunlap, Laura J.
    Turcios, Didier
    Wolicki, Sara Beth
    Edlund, Mark J.
    Losby, Jan L.
    SUBSTANCE USE & ADDICTION JOURNAL, 2025, 46 (02): : 266 - 279
  • [24] Quit ratios for cigarette smoking among individuals with opioid misuse and opioid use disorder in the United States
    Parker, Maria A.
    Weinberger, Andrea H.
    Villanti, Andrea C.
    DRUG AND ALCOHOL DEPENDENCE, 2020, 214
  • [25] Polysubstance use patterns among individuals applying for opioid-use disorder treatment in the US
    Lee-Easton, Miranda
    Magura, Stephen
    Abu-Obaid, Ruqayyah
    Reed, Pete
    Allgaier, Brandi
    Fish, Emily
    Maletta, Abigail L.
    Amaratunga, Piyadarsha
    Lorenz-Lemberg, Bridget
    Levitas, Matthew
    Achtyes, Eric D.
    JOURNAL OF SUBSTANCE USE, 2024,
  • [26] Stigmatization of Pregnant Individuals with Opioid Use Disorder
    Crawford, Allison D.
    McGlothen-Bell, Kelly
    Recto, Pamela
    McGrath, Jacqueline M.
    Scott, Leticia
    Brownell, Elizabeth A.
    Cleveland, Lisa M.
    WOMENS HEALTH REPORTS, 2022, 3 (01): : 172 - 179
  • [27] Methamphetamine Use and Its Correlates among Individuals with Opioid Use Disorder in a Midwestern US City
    Daniulaityte, Raminta
    Silverstein, Sydney M.
    Crawford, Timothy N.
    Martins, Silvia S.
    Zule, William
    Zaragoza, Angela J.
    Carlson, Robert G.
    SUBSTANCE USE & MISUSE, 2020, 55 (11) : 1781 - 1789
  • [28] Psilocybin use patterns and perception of risk among a cohort of Black individuals with Opioid Use Disorder
    Clifton, John M.
    Belcher, Annabelle M.
    Greenblatt, Aaron D.
    Welsh, Christopher M.
    Cole, Thomas O.
    Davis, Alan K.
    JOURNAL OF PSYCHEDELIC STUDIES, 2022, 6 (02): : 80 - 87
  • [29] Predictors of Buprenorphine Formulation Preferences Among Individuals Experiencing Homelessness With Opioid Use Disorder
    Masson, Carmen
    Shopshire, Michael
    Knight, Kelly
    Suen, Leslie
    Swinkels, Marcus
    Schwartz, Robert
    Coffin, Phillip
    Sorensen, James
    DRUG AND ALCOHOL DEPENDENCE, 2025, 267
  • [30] The receipt of medications for opioid use disorder among pregnant individuals in the USA: a multilevel analysis
    Curran, Laura
    Manuel, Jennifer
    DRUGS HABITS AND SOCIAL POLICY, 2024, 25 (01): : 51 - 66